Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Máxima-topman Eggermont: ‘We beseffen niet hoe ver we vóórlopen’
jul 2020